ASTEX PHARMACEUTICALS, INC Comprehensive Income
ASTEX PHARMACEUTICALS, INC reported Comprehensive Income of -$3.98 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2013-08-09
- ASTEX PHARMACEUTICALS, INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2013-06-30 was -$3.98M.
- ASTEX PHARMACEUTICALS, INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2013-03-31 was -$5.60M, a 152.13% decline year-over-year.
- ASTEX PHARMACEUTICALS, INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-12-31 was $3.72M.
- ASTEX PHARMACEUTICALS, INC comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2012-09-30 was $2.81M.
- ASTEX PHARMACEUTICALS, INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2012 was $13.14M.
- ASTEX PHARMACEUTICALS, INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was -$3.52M, a 119.69% decline from fiscal 2010.
- ASTEX PHARMACEUTICALS, INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2010 was $17.86M, a 183.28% increase from fiscal 2009.
- ASTEX PHARMACEUTICALS, INC comprehensive income (loss), net of tax, attributable to parent for fiscal 2009 was $6.30M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$3.98M 10-Q · filed 2013-08-09 | -$9.58M 10-Q · filed 2013-08-09 | -$5.86M derived: sum of 3 quarters · filed 2013-08-09 | -$3.04M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | -$5.60M 10-Q · filed 2013-05-10 | -$1.88M derived: sum of 2 quarters · filed 2013-05-10 | $935.00K derived: sum of 3 quarters · filed 2013-05-10 | -$3.21M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $6.54M derived: sum of 2 quarters · filed 2013-03-18 | $2.39M derived: sum of 3 quarters · filed 2013-08-09 | $13.14M 10-K · filed 2013-03-18 |
| 2012-09-30 | $2.81M 10-Q · filed 2012-11-09 | -$1.33M derived: sum of 2 quarters · filed 2013-08-09 | $9.42M 10-Q · filed 2012-11-09 | $7.23M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | -$4.15M 10-Q · filed 2013-08-09 | $6.60M 10-Q · filed 2013-08-09 | $4.42M derived: sum of 3 quarters · filed 2013-08-09 | -$1.71M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $10.75M 10-Q · filed 2013-05-10 | $8.57M derived: sum of 2 quarters · filed 2013-05-10 | $2.44M derived: sum of 3 quarters · filed 2013-05-10 | $2.31M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | -$2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$8.31M derived: sum of 2 quarters · filed 2013-03-18 | -$8.44M derived: sum of 3 quarters · filed 2013-03-18 | -$3.52M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$6.13M 10-Q · filed 2012-11-09 | -$6.25M derived: sum of 2 quarters · filed 2012-11-09 | -$1.33M 10-Q · filed 2012-11-09 | |
| 2011-06-30 | -$121.00K 10-Q · filed 2012-08-09 | $4.80M 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $4.92M 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | $17.86M 10-K · filed 2013-03-18 | |||
| 2009-12-31 | $6.30M 10-K · filed 2012-03-15 |